Cargando…
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
BACKGROUND: Gleason scoring (GS) has major deficiencies and a novel system of five grade groups (GS⩽6; 3+4; 4+3; 8; ⩾9) has been recently agreed and included in the WHO 2016 classification. Although verified in radical prostatectomies using PSA relapse for outcome, it has not been validated using pr...
Autores principales: | Berney, Daniel M, Beltran, Luis, Fisher, Gabrielle, North, Bernard V, Greenberg, David, Møller, Henrik, Soosay, Geraldine, Scardino, Peter, Cuzick, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865975/ https://www.ncbi.nlm.nih.gov/pubmed/27100731 http://dx.doi.org/10.1038/bjc.2016.86 |
Ejemplares similares
-
The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019) -
Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018) -
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013) -
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015) -
Reply to ‘Comment on “Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome”’
por: Berney, Daniel M
Publicado: (2017)